Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for GoodRx Holdings Inc. (GDRX:NASDAQ), powered by AI.
GoodRx Holdings Inc. is currently trading at $2.73. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for GoodRx Holdings Inc. on Alpha Lenz.
GoodRx Holdings Inc.'s P/E ratio is 32.0.
“GoodRx Holdings Inc. trades at a P/E of 32.0 (premium valuation) with modest ROE of 4.5%.”
Ask for details →GoodRx Holdings Inc. is a leading digital healthcare platform that aims to make prescription drugs more affordable and accessible for consumers across the United States. By providing a convenient service that aggregates pricing data from over 70,000 pharmacies, GoodRx helps users find cost-effective options for medications through discounts, coupons, and comparison tools. The platform plays a critical role in the healthcare sector, addressing the widespread issue of high medication costs that affect millions of Americans. Its services cater to individuals who may lack insurance or need assistance in navigating prescription prices, thus prominently impacting the retail pharmacy and healthcare sectors. Headquartered in Santa Monica, California, GoodRx leverages its technology-driven approach to foster transparency in drug pricing, making healthcare more consumer-friendly and economically manageable.
“GoodRx Holdings Inc. trades at a P/E of 32.0 (premium valuation) with modest ROE of 4.5%.”
Ask for details →GoodRx Holdings Inc. (ticker: GDRX) is a company listed on NASDAQ in the Healthcare sector (Health Information Services). It has approximately 738 employees. Market cap is $973M.
The current price is $2.73 with a P/E ratio of 31.96x and P/B of 1.58x.
ROE is 4.54% and operating margin is 10.98%. Annual revenue is $797M.